Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Baillie

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 23, 2006
Current status of the prevention of cytomegalovirus disease in solid organ transplant recipients. IntroductionG Mark Baillie
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 23, 2006
Prevention of cytomegalovirus disease in solid organ transplant patients: prophylactic versus preemptive therapyG Mark Baillie
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 12, 2005
Pharmacokinetics of antiviral agents for the treatment of cytomegalovirus infectionG Mark Baillie
Clinical Transplantation|February 5, 2009
Hematologic complications of anti-CMV therapy in solid organ transplant recipientsLara Danziger-Isakov, G Mark Baillie
CPT: Pharmacometrics & Systems Pharmacology|July 23, 2019
Effective Visual Communication for the Quantitative ScientistMarc Vandemeulebroecke, Mark Baillie, Alison Margolskee, et al.
Pharmaceutical Statistics|June 25, 2025
Estimating the Variance of Covariate-Adjusted Estimators of Average Treatment Effects in Clinical Trials With Binary EndpointsDominic Magirr, Craig Wang, Alexander Przybylski, et al.
Pharmacotherapy|January 27, 2010
Defining the risks for cytomegalovirus infection and disease after solid organ transplantationRobert J Stratta, Carolynn Pietrangeli, G Mark Baillie
Trials|April 21, 2023
DMC reports in the 21st century: towards better tools for decision-makingMarc Vandemeulebroecke, Mark Baillie, Ardalan Mirshani, et al.
Plos One|February 7, 2008
The efficacy of emamectin benzoate against infestations of Lepeophtheirus salmonis on farmed Atlantic salmon (Salmo salar L) in Scotland, 2002-2006Fiona Lees, Mark Baillie, George Gettinby, et al.
Scientific Data|November 10, 2022
Rethinking clinical study data: why we should respect analysis results as dataJoana M Barros, Lukas A Widmer, Mark Baillie, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 23, 2006
Current status of the prevention of cytomegalovirus disease in solid organ transplant recipients. IntroductionG Mark Baillie
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 23, 2006
Prevention of cytomegalovirus disease in solid organ transplant patients: prophylactic versus preemptive therapyG Mark Baillie
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 12, 2005
Pharmacokinetics of antiviral agents for the treatment of cytomegalovirus infectionG Mark Baillie
Clinical Transplantation|February 5, 2009
Hematologic complications of anti-CMV therapy in solid organ transplant recipientsLara Danziger-Isakov, G Mark Baillie
CPT: Pharmacometrics & Systems Pharmacology|July 23, 2019
Effective Visual Communication for the Quantitative ScientistMarc Vandemeulebroecke, Mark Baillie, Alison Margolskee, et al.
Pharmaceutical Statistics|June 25, 2025
Estimating the Variance of Covariate-Adjusted Estimators of Average Treatment Effects in Clinical Trials With Binary EndpointsDominic Magirr, Craig Wang, Alexander Przybylski, et al.
Pharmacotherapy|January 27, 2010
Defining the risks for cytomegalovirus infection and disease after solid organ transplantationRobert J Stratta, Carolynn Pietrangeli, G Mark Baillie
Trials|April 21, 2023
DMC reports in the 21st century: towards better tools for decision-makingMarc Vandemeulebroecke, Mark Baillie, Ardalan Mirshani, et al.
Plos One|February 7, 2008
The efficacy of emamectin benzoate against infestations of Lepeophtheirus salmonis on farmed Atlantic salmon (Salmo salar L) in Scotland, 2002-2006Fiona Lees, Mark Baillie, George Gettinby, et al.
Scientific Data|November 10, 2022
Rethinking clinical study data: why we should respect analysis results as dataJoana M Barros, Lukas A Widmer, Mark Baillie, et al.
Pageof 4